{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:54Z","timestamp":1793726574143,"version":"4.6.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jaad.2022.06.1201","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T23:00:33Z","timestamp":1657148433000},"page":"683-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States"],"prefix":"10.1016","volume":"88","author":[{"given":"Jeremy A.W.","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2022.06.1201_bib1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jdcr.2020.05.025","article-title":"Treatment-resistant dermatophytosis: a representative case highlighting an emerging public health threat","volume":"6","author":"Gu","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2022.06.1201_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.19146","article-title":"Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial","volume":"183","author":"Singh","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.06.1201_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0190-9622(96)90843-9","article-title":"Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines\/Outcomes Committee. American Academy of Dermatology","volume":"34","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.06.1201_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.06.1201_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaad.2019.12.019","article-title":"Diagnostic testing for onychomycosis: a retrospective study over 17 years","volume":"83","author":"Geizhals","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222022526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222022526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:07:50Z","timestamp":1759273670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222022526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0190962222022526"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.06.1201","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.06.1201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}